Nurofen

Nurofen
Name	Nurofen
Uses	Analgesic, antipyretic, anti-inflammatory
Chemical class	Nonsteroidal anti-inflammatory drug
Active ingredient	Ibuprofen
Routes of administration	Oral, topical
Legal status	Over-the-counter/Prescription (varies)

Nurofen is a brand of analgesic products primarily containing the nonsteroidal anti-inflammatory drug ibuprofen, marketed for relief of pain, fever, and inflammation. Launched and expanded through major pharmaceutical and consumer healthcare companies, the brand has been sold in retail, pharmacy, and online channels across multiple countries, influencing public discussions on drug labelling, comparative advertising, and regulatory oversight. Its formulations range from tablets and capsules to syrups and topical gels, and the product has been involved in litigation, investigations, and marketing disputes.

History

The product line was introduced by an international pharmaceutical company and later managed within portfolios associated with firms like Reckitt, Boots Group, and other multinational corporations, paralleling developments involving Pfizer, GlaxoSmithKline, Johnson & Johnson, Novartis, Roche, Sanofi, AstraZeneca, Merck & Co., Eli Lilly and Company, Bayer, Takeda Pharmaceutical Company, AbbVie, Boehringer Ingelheim, Astellas, Novo Nordisk, Bristol-Myers Squibb, Amgen, Gilead Sciences, Celgene, Allergan, Mallinckrodt, Endo International, Valeant Pharmaceuticals International, Janssen Pharmaceuticals, Lilly, King Pharmaceuticals, Shire, Ipsen, UCB S.A., Mylan, Teva Pharmaceutical Industries, Sun Pharma, Dr. Reddy's Laboratories, Cipla, Sanofi Aventis, Eisai, Takeda, Servier, Fresenius Kabi, Grifols, CSL Limited and Merck KGaA. Early market expansion coincided with regulatory frameworks shaped by agencies such as the Medicines and Healthcare products Regulatory Agency, the Food and Drug Administration, the European Medicines Agency, the Therapeutic Goods Administration (Australia), and national authorities in markets including United Kingdom, Australia, United States, Canada, Germany, France, Italy, Spain, Japan, China, India, Brazil, South Africa, Russia, Mexico, Argentina, Sweden, Netherlands, Belgium, Switzerland, Norway, Denmark, Finland, Ireland, Poland, Portugal, Greece, Turkey, Israel, Saudi Arabia, United Arab Emirates, Singapore, South Korea, New Zealand, Egypt, Chile, Colombia, Peru, Venezuela, Thailand, Malaysia, Philippines, Indonesia, Vietnam, Pakistan, Bangladesh, Nepal, Sri Lanka, Kenya, Nigeria, Ghana, Morocco, Algeria, Tunisia, Hungary, Czech Republic, Slovakia, Romania, Bulgaria, Croatia, Slovenia, Lithuania, Latvia, Estonia, Iceland. Public attention to over-the-counter analgesics in the late 20th and early 21st centuries involved debates linked to high-profile events and institutions such as the World Health Organization, United Nations, G20, European Commission, European Parliament, House of Commons, House of Lords, U.S. Congress, Supreme Court of the United Kingdom, High Court of Australia, and major media outlets including BBC, The Guardian, The New York Times, The Wall Street Journal, The Washington Post, Financial Times.

Formulations and Active Ingredients

The brand’s primary active ingredient is ibuprofen, a propionic acid derivative discovered by researchers affiliated historically with companies and institutions like Boots (company), University of Manchester, Imperial College London, University of Oxford, University of Cambridge, Royal Society of Chemistry, National Institutes of Health, Wellcome Trust, Medical Research Council, King's College London, St Bartholomew's Hospital, Addenbrooke's Hospital, Mayo Clinic, Cleveland Clinic, Johns Hopkins University, Harvard University, Yale University, Columbia University, Stanford University, Massachusetts Institute of Technology, University of California, San Francisco, University of Toronto, McGill University, Karolinska Institutet, Max Planck Society, CNRS, University of Tokyo, Peking University, Tsinghua University, Seoul National University, Monash University, and University of Melbourne. Formulations include immediate-release tablets, modified-release tablets, caplets, soft gel capsules, effervescent tablets, oral suspensions, and topical gels/creams; several products combine ibuprofen with adjuncts such as antacids or local analgesics, paralleling combination therapies produced by other manufacturers like GlaxoSmithKline and Johnson & Johnson. Packaging and excipients have varied to meet regulations from agencies such as the Food and Drug Administration and European Medicines Agency.

Medical Uses and Efficacy

Ibuprofen-containing products are indicated for symptomatic relief of headache, dental pain, musculoskeletal pain, dysmenorrhea, minor injury, and fever; efficacy assessments feature in clinical literature from institutions like Cochrane Collaboration, BMJ, Lancet, New England Journal of Medicine, Annals of Internal Medicine, JAMA, Nature Medicine, Science Translational Medicine, PLOS Medicine and trials conducted at hospitals including Addenbrooke's Hospital and Mayo Clinic. Comparative effectiveness studies often reference agents such as aspirin, paracetamol (acetaminophen), naproxen, diclofenac, celecoxib, ibuprofen lysine, ketoprofen, indomethacin, meloxicam and prescription analgesics from companies like Pfizer and Bayer. Systematic reviews evaluate outcomes including pain intensity reduction, time to meaningful relief, duration of action, and adverse events, informing clinical guidance from the World Health Organization, the National Institute for Health and Care Excellence, the American College of Physicians, and specialty societies such as the American Dental Association and American College of Rheumatology.

Dosage and Administration

Recommended dosages align with clinical pharmacology and regulatory labeling reviewed by authorities like the European Medicines Agency and Food and Drug Administration, and are informed by pharmacokinetic studies from research centers including University College London and Karolinska Institutet. Typical adult dosing for over-the-counter formulations follows conservative limits compared with prescription regimens used in rheumatology or postoperative pain managed at facilities such as Royal London Hospital, Guy's Hospital, Cleveland Clinic, and Mayo Clinic. Pediatric dosing is weight-based and subject to national immunization and pediatric guidelines from institutions such as American Academy of Pediatrics, Royal College of Paediatrics and Child Health, and Paediatric societies in numerous countries. Directions vary for oral versus topical administration, and cautions address concomitant use with agents produced by firms such as Pfizer (warfarin-containing anticoagulants historically developed by various companies), AstraZeneca, Gilead Sciences, and others influencing drug–drug interaction considerations.

Side Effects and Safety

Safety profiles are described in pharmacovigilance reports from agencies including the Medicines and Healthcare products Regulatory Agency, the Food and Drug Administration, and the European Medicines Agency, and discussed in journals like BMJ and The Lancet. Recognized adverse effects include gastrointestinal irritation and bleeding, renal impairment, cardiovascular risks, hypersensitivity reactions including asthma exacerbations, and cutaneous reactions; these risks are analyzed alongside data from large healthcare systems such as NHS England, Centers for Disease Control and Prevention, Veterans Health Administration, Kaiser Permanente, Health Canada, Australian Therapeutic Goods Administration, and academic centers like Johns Hopkins Hospital. Warnings concern use in pregnancy referencing guidance from organizations including the Royal College of Obstetricians and Gynaecologists, the American College of Obstetricians and Gynecologists, and teratology research from institutions like European Teratology Society.

Regulatory and Legal Issues

The brand has been subject to regulatory scrutiny, compliance reviews, and legal actions in jurisdictions overseen by bodies such as the Competition and Markets Authority (UK), the Australian Competition and Consumer Commission, the United States Federal Trade Commission, national courts including the High Court of Justice (England and Wales), and appellate tribunals. Litigation has involved advertising claims, trademark disputes, and consumer protection cases that engaged law firms, retail chains like Boots (company), Walgreens, CVS Health, Rite Aid, Walmart and trade associations. Regulatory decisions have intersected with policy debates involving the European Commission, Parliamentary committees, and consumer advocacy groups such as Which? and Choice.

Marketing and Controversies

Marketing strategies and controversies have generated reporting in media outlets including BBC, The Guardian, The Times, Financial Times, The New York Times, The Wall Street Journal and regulatory findings by bodies like the Advertising Standards Authority (UK). Disputes centered on targeted claims for specific pain types led to investigations and corrective actions involving corporate communications teams and external agencies, in contexts similar to other high-profile consumer-health controversies involving companies such as Johnson & Johnson (talc litigation), Pfizer (promotional practices), and GlaxoSmithKline (regulatory settlements). Public debates about over-the-counter analgesic labelling, pharmacy practice, and consumer choice have also engaged professional bodies like the Royal Pharmaceutical Society, American Pharmacists Association, British Medical Association and patient advocacy organizations.

Category:Analgesics